Претрага

Резултати

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia [2012]

Robak, Tadeusz; Windyga, Jerzy; Trelinski, Jacek; von, Depka Prondzinski Mario; Giagounidis, Aristoteles; Doyen, Chantal; Janssens, Ann; Álvarez-Román, María Teresa; Jarque, Isidro; Loscertales, Javier;

Rus, Gloria Pérez; Hellmann, Andrzej; Jêdrzejczak, Wiesław Wiktor; Kuliczkowski, Kazimierz; Golubovic, Lana M.; Celeketic, Dusica; Cucuianu, Andrei; Gheorghita, Emanuil; Lazaroiu, Mihaela; Shpilberg, Ofer; Attias, Dina; Karyagina, Elena; Svetlana, Kalinina; Vilchevska, Kateryna; Cooper, Nichola; Talks, Kate; Prabhu, Mukhyaprana; Sripada, Prasad; Bharadwaj, T. P. R.; Næsted, Henrik; Skartved, Niels J. Ø.; Frandsen, Torben P.; Flensburg, Mimi F.; Andersen, Peter S.; Petersen, Jørgen;

Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgical Procedures - Results From the guardian (TM) Trials [2012]

Santagostino, Elena; Lentz, SR; Misgav, M; Brand, B; Chowdary, Pratima; Savic, Aleksandar D ; Kilinc, Yurdanur; Tuddenham, Edward GD; Lindblom, A

Oral treatment with PBI-1402 increases hemoglobin level and red blood cell count: A novel approach to treating chemotherapy-induced anemia. [2007]

Gagnon, Lyric; Barabe, Jean; Penney, Christopher; Roy, Denis-Claude; Kovcin, Vladimir N; Bosnjak, Snezana M; Laurin, Pierre

Erythropoietin signaling and response in vascular smooth muscle cells. [2007]

Beleslin-Čokić, Bojana B. ; Čokić, Vladan P. ; Gojkovic-Bukarica, Ljiljana C ; Noguchi, Constance Tom

High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "IST [2010]

Perzeri, Andreas L; ...; Bogdanovic, Andrija D ; ...; (broj, koautora 20)

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL [2022]

Antić, Darko A. ; Milić, Nataša M. ; ...; Otašević, Vladimir; Rajović, Nina Z. ; ...; Mihaljević, Biljana S. ; Milošević, Ivana D. ; ...; Tomić, Kristina;

...; Vuković, Vojin M. ; ...; (broj koautora 101);

Foxo3 transcription factor regulates oxidative stress in in vivo erythropoiesis. [2006]

Marinković, Dragan ; Zhang, Xin; Brugnara, Carlo; Ghaffari, Saghi

Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis [2023]

Pemmaraju, Naveen; ...; Bogdanović, Andrija D. ; ...; (broj koautora 24)

Disease evolution and outcomes in familial AML with germline CEBPA mutations [2015]

Tawana, Kiran; Wang, Jun; Renneville, Aline; Bödör, Csaba; Hills, Robert; Loveday, Chey; Savić, Aleksandar ; Van, Delft Frederik W.; Treleaven, Jennifer; Georgiades, Panayiotis;

Uglow, Elizabeth; Asou, Norio; Uike, Naokuni; Debeljak, Maruša; Jazbec, Janez; Ancliff, Philip; Gale, Rosemary; Thomas, Xavier; Mialou, Valerie; Döhner, Konstanze; Bullinger, Lars; Mueller, Beatrice; Pabst, Thomas; Stelljes, Matthias; Schlegelberger, Brigitte; Wozniak, Eva; Iqbal, Sameena; Okosun, Jessica; Araf, Shamzah; Frank, Anne-Katrine; Lauridsen, Felicia B.; Porse, Bo; Nerlov, Claus; Owen, Carolyn; Dokal, Inderjeet; Gribben, John; Smith, Matthew; Preudhomme, Claude; Chelala, Claude; Cavenagh, Jamie; Fitzgibbon, Jude;

Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry [2016]

Langemeijer, Saskia; ...; Savic, Aleksandar D ; ...; (broj, koautora 26)